NASDAQ:ALGS | Income Statement | Aligos Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$0.00$24.05M$29.67M-$1.89M$1.31M$2.81M-$1.5M-$0.14-$0.1410,430,80810,430,808
2026-03-31$2.83M$23.35M$29.76M-$26.93M-$22.72M$317,000.00-$23.04M-$2.21-$2.2110,402,96710,402,967
2025-12-31$169,000.00$17.04M$21.98M-$21.81M-$19.85M$30,000.00-$19.88M-$2.01-$2.01168,060168,060
2025-09-30$741,000.00$23.94M$29.1M-$28.36M-$31.48M$56,000.00-$31.54M-$3.04-$3.0410,369,53510,369,535
2025-06-30$965,000.00$13.98M$19.53M-$18.57M-$15.68M$185,000.00-$15.86M-$1.53-$1.5310,351,12010,351,120
2025-03-31$311,000.00$14.5M$19.55M-$19.24M$43.13M$43,000.00$43.09M$5.12-$2.118,408,4818,709,693
2024-12-31$606,000.00$16.03M$21.19M-$20.56M-$82.12M$27,000.00-$82.15M-$13.10-$13.105,9065,906
2024-09-30$1.25M$16.77M$21.4M-$20.13M-$19.17M$91,000.00-$19.26M-$3.07-$3.076,272,2916,272,291
2024-06-30$1.06M$21.1M$27.48M-$26.41M$5.25M$189,000.00$5.06M$0.81$0.816,257,7136,265,853
2024-03-31$694,000.00$16.37M$23.03M-$22.05M-$34.84M$24,000.00-$34.86M-$5.58-$5.586,246,1136,246,113
2023-12-31$672,000.00$22.26M$28.68M-$26M-$27.92M-$30,000.00-$27.89M$0.39$0.39835,188835,188
2023-09-30$1.09M$15.87M$22.31M-$19.07M-$18.01M$29,000.00-$18.04M-$10.37-$10.371,739,8471,739,847
2023-06-30$4.29M$16.78M$26.03M-$19.14M-$18.03M$757,000.00-$18.79M-$0.43-$0.4343,215,47843,215,478
2023-03-31$140,000.00$18.14M$26.64M-$23.92M-$22.92M$39,000.00-$22.96M-$0.53-$0.5342,910,06542,910,065
2022-12-31$0.00$19.1M$26.22M-$22.68M-$21.84M$49,000.00-$21.89M-$0.51-$0.5147,49547,495
2022-09-30$0.00$17.79M$23.05M-$18.95M-$18.66M-$43,000.00-$18.62M-$0.44-$0.4442,761,92842,761,928
2022-06-30$0.00$16.51M$24.09M-$20.39M-$19.88M$47,000.00-$19.92M-$0.47-$0.4742,665,59842,665,598
2022-03-31$31.68M$38.13M-$35.56M-$35.56M$53,000.00-$35.62M-$0.84-$0.8442,511,55942,511,559
2021-12-31$28.6M$38.32M-$37.95M-$37.77M-$58,000.00-$37.71M704,308
2021-09-30$28.13M$34.61M-$33.07M-$33M$126,000.00-$33.12M-$0.78-$0.7842,399,98442,399,984
2021-06-30$24.55M$31.11M-$29.57M-$29.79M$28,000.00-$29.82M37,619,039
2021-03-31$22.87M$28.65M-$27.74M-$27.63M$45,000.00-$27.67M37,434,261
2020-12-31$28.08M$34.29M-$34.29M-$34.2M$219,000.00-$34.42M7,159,031
2020-09-30$17.33M$21.56M-$21.56M-$33.3M$0.00-$33.3M3,027,825
2020-06-30$17.18M$21.27M-$21.27M-$20.86M-$59,000.00-$20.8M2,810,854
2020-03-31$17.3M$20.72M-$20.72M-$20.03M-$20.03M2,648,885
2019-12-31$14.97M$18.44M-$18.44M-$18.1M-$18.18M155,362
2019-09-30$11.73M$14.5M-$14.5M-$14.05M-$14.05M2,084,719

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$2.19M$69.45M$90.17M-$87.99M-$23.88M$314,000.00-$24.19M-$2.45-$2.459,884,9559,884,955
2024-12-31$3.61M$70.27M$93.1M-$89.15M-$130.88M$331,000.00-$131.21M-$20.94-$20.946,264,6126,264,612
2023-12-31$6.19M$73.04M$103.66M-$88.13M-$86.88M$795,000.00-$87.68M-$34.20-$34.202,563,4702,563,470
2022-12-31$0.00$85.08M$111.49M-$97.58M-$95.94M$106,000.00-$96.05M-$2.25-$2.2542,695,22742,695,227
2021-12-31$0.00$104.15M$132.68M-$128.32M-$128.19M$143,000.00-$128.33M39,855,403
2020-12-31$0.00$79.89M$97.83M-$97.83M-$108.38M$161,000.00-$108.54M9,988,191
2019-12-31$44.04M$54.04M-$54.04M-$52.18M$85,000.00-$52.26M2,007,173